Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

Details

Serval ID
serval:BIB_7EEEC9398BEA
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.
Journal
Blood
Author(s)
Chung D.J., Rossi M., Romano E., Ghith J., Yuan J., Munn D.H., Young J.W.
ISSN
1528-0020 (Electronic)
ISSN-L
0006-4971
Publication state
Published
Issued date
2009
Volume
114
Number
3
Pages
555-563
Language
english
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Abstract
A comprehensive understanding of the complex, autologous cellular interactions and regulatory mechanisms that occur during normal dendritic cell (DC)-stimulated immune responses is critical to optimizing DC-based immunotherapy. We have found that mature, immunogenic human monocyte-derived DCs (moDCs) up-regulate the immune-inhibitory enzyme, indoleamine 2,3-dioxygenase (IDO). Under stringent autologous culture conditions without exogenous cytokines, mature moDCs expand regulatory T cells (Tregs) by an IDO-dependent mechanism. The priming of resting T cells with autologous, IDO-expressing, mature moDCs results in up to 10-fold expansion of CD4(+)CD25(bright)Foxp3(+)CD127(neg) Tregs. Treg expansion requires moDC contact, CD80/CD86 ligation, and endogenous interleukin-2. Cytofluorographically sorted CD4(+) CD25(bright)Foxp3(+) Tregs inhibit as much as 80% to 90% of DC-stimulated autologous and allogeneic T-cell proliferation, in a dose-dependent manner at Treg:T-cell ratios of 1:1, 1:5, and as low as 1:25. CD4(+)CD25(bright)Foxp3(+) Tregs also suppress the generation of cytotoxic T lymphocytes specific for the Wilms tumor antigen 1, resulting in more than an 80% decrease in specific target cell lysis. Suppression by Tregs is both contact-dependent and transforming growth factor-beta-mediated. Although mature moDCs can generate Tregs by this IDO-dependent mechanism to limit otherwise unrestrained immune responses, inhibition of this counter-regulatory pathway should also prove useful in sustaining responses stimulated by DC-based immunotherapy.
Keywords
Antigen Presentation, Cell Proliferation, Cells, Cultured, Dendritic Cells/enzymology, Dendritic Cells/immunology, Humans, Immunotherapy, Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics, Indoleamine-Pyrrole 2,3,-Dioxygenase/immunology, Monocytes, T-Lymphocytes/cytology, T-Lymphocytes/immunology, T-Lymphocytes, Cytotoxic, T-Lymphocytes, Regulatory/cytology, T-Lymphocytes, Regulatory/immunology, Up-Regulation/genetics
Pubmed
Web of science
Open Access
Yes
Create date
25/10/2011 13:18
Last modification date
20/08/2019 14:39
Usage data